AIM ImmunoTech, Inc. (AIM) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Cumberland Pharmaceuticals, Inc.

NRX Pharmaceuticals, Inc.

Indaptus Therapeutics, Inc.

Context Therapeutics, Inc.

KALA BIO, Inc.

MyMD Pharmaceuticals, Inc.

AIM ImmunoTech, Inc.

Genprex, Inc.

NLS Pharmaceutics Ltd.

AgeX Therapeutics, Inc.

Regulus Therapeutics, Inc.

Why is AIM ImmunoTech, Inc. ?

Unrated Stock - No Analysis Available

Real-Time Research Report

Verdict Report

No Data Found

Is AIM ImmunoTech, Inc. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

AIM ImmunoTech, Inc.

-92.05%

-0.30

208.70%

S&P 500

15.76%

1.17

13.09%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-1.23%

EBIT Growth (5y)

-1.27%

EBIT to Interest (avg)

-20.43

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

0.02

Sales to Capital Employed (avg)

0.01

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

13.48%

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

-0.49

EV to EBIT

-0.19

EV to EBITDA

-0.19

EV to Capital Employed

-0.42

EV to Sales

2.66

PEG Ratio

Dividend Yield

4464.49%

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

Negative BV

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

RSI

No Signal

Bullish

Bollinger Bands

Bearish

Mildly Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

4What is working for the Company

NET PROFIT(HY)

Higher at USD -6.32 MM

EPS(Q)

Highest at USD -0.22

-18What is not working for the Company

INTEREST(HY)

At USD 0.6 MM has Grown at 119.41%

NET SALES(9M)

At USD 0.07 MM has Grown at -19.77%

ROCE(HY)

Lowest at -2,382.3%

PRE-TAX PROFIT(Q)

At USD -3.76 MM has Fallen at -49.72%

NET PROFIT(Q)

At USD -3.76 MM has Fallen at -49.72%

RAW MATERIAL COST(Y)

Grown by 1,111.8% (YoY

OPERATING PROFIT(Q)

Lowest at USD -2.96 MM

Here's what is working for AIM ImmunoTech, Inc.

EPS

Highest at USD -0.22

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (USD)

Here's what is not working for AIM ImmunoTech, Inc.

Interest

At USD 0.6 MM has Grown at 119.41%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (USD MM)

Pre-Tax Profit

At USD -3.76 MM has Fallen at -49.72%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (USD MM)

Net Profit

At USD -3.76 MM has Fallen at -49.72%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (USD MM)

Net Sales

At USD 0.07 MM has Grown at -19.77%

Year on Year (YoY)

MOJO Watch

Near term sales trend is negative

Net Sales (USD MM)

Operating Profit

Lowest at USD -2.96 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (USD MM)

Raw Material Cost

Grown by 1,111.8% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales